Lilly Postdoc Jobs (NOW HIRING)

Job Summary:
Eli Lilly and Company is a leading pharmaceutical research organization seeking a highly motivated Postdoctoral Scientist in CNS Neuroimaging. This role involves applying multimodal neuroimaging and quantitative data analytics to support CNS therapeutic development and enable data-driven decision making in drug delivery strategies.
Responsibilities:
• Receive, organize, curate, and analyze multimodal CNS neuroimaging datasets, including but not limited to MRI, CT, and complementary imaging approaches used in CNS drug delivery research.
• Apply advanced quantitative analysis methods across neuroimaging modalities relevant to regional CNS exposure, delivery efficiency, anatomical specificity, tissue response, and longitudinal change.
• Perform standard preprocessing and analysis workflows, including registration, segmentation, artifact assessment, and region‑based quantification.
• Implement atlas‑based registration and segmentation using established CNS atlases (e.g., Allen Brain Atlas, Paxinos, and higher‑vertebrate atlases) as a required skill for regional exposure and biodistribution analysis.
• Manage large, multi‑study imaging datasets with strong attention to data integrity, reproducibility, and documentation aligned with CNS research and regulatory expectations.
• Demonstrate deep working knowledge of neuroimaging software platforms such as FSL, ANTs, ITK‑SNAP, and 3D Slicer; these are considered table‑stakes tools for the role.
• Develop and maintain custom Python‑based image analysis workflows and scalable pipelines tailored to CNS drug delivery research.
• Apply modern data analytics and visualization techniques to extract and communicate CNS‑relevant insights.
• Lead co‑registration and integration of neuroimaging data with histology, IHC, and molecular biodistribution readouts.
• Serve as a scientific bridge between imaging and biodistribution teams, enabling coherent interpretation across spatial, anatomical, and molecular scales.
• Translate complex neuroimaging datasets into clear, interpretable visualizations and summaries for project teams and leadership audiences.
• Act as a scientific interface between DDCS, Lilly neuroscience and genomic medicine teams, and external CRO partners on neuroimaging strategy, data quality, and analytical approaches.
• Clearly communicate imaging data needs, timelines, and quality expectations to external collaborators while advocating for CNS program priorities.
• Collaborate with internal experts across neuroscience, gene therapy, toxicology, pharmacology, and bioinformatics to embed neuroimaging data into broader CNS therapeutic strategies.
• Provide scientific and technical input to CROs to improve image quality, resolution, contrast, and interpretability for CNS applications.
• Contribute to optimization of imaging protocols addressing CNS‑specific challenges such as motion, susceptibility artifacts, small anatomical targets, and longitudinal consistency.
• Ensure acquisition strategies support cross‑study and cross‑site comparability.
• Contribute to the development of standardized, scalable neuroimaging analysis pipelines tailored to CNS drug delivery and translational research.
• Explore and apply emerging neuroimaging and analytical approaches as appropriate to evolving CNS therapeutic modalities.
Qualifications:
Required:
• PhD in Imaging Sciences, Biomedical Engineering, Medical Physics, Neuroscience, Physics, Computer Science, or a closely related quantitative field.
• Demonstrated experience in neuroimaging data handling and analysis, including standard preprocessing and quantitative analysis techniques.
• Strong programming experience for image analysis, preferably in Python.
• Experience working with large datasets and communicating scientific insights through effective visualization.
• Ability to work independently while contributing effectively within multidisciplinary, matrixed research teams.
• Excellent written and verbal communication skills, with comfort engaging both technical and non‑technical stakeholders.
• Qualified applicants must be authorized to work in the United States on a full-time basis. Lilly will not provide support for or sponsor work authorization or visas for this role, including but not limited to F-1 CPT, F-1 OPT, F-1 STEM OPT, J-1, H-1B, TN, O-1, E-3, H-1B1, or L-1.
Preferred:
• Hands‑on experience with preclinical and/or in vivo CNS studies, including animal models of neurological disease.
• Working knowledge of neuroimaging physics and contrast mechanisms (MRI and/or other modalities) as they relate to neuroanatomy and CNS pathology.
• Experience collaborating with CROs on neuroimaging acquisition or analysis in a therapeutic development context.
• Prior exposure to pharmaceutical, biotech, or translational neuroscience research environments.
• Strong interest in CNS drug delivery, gene therapy, neurodegeneration, or advanced neuroimaging methodologies.
Company:
We're a medicine company turning science into healing to make life better for people around the world. Founded in 1876, the company is headquartered in Indianapolis, USA, with a team of 10001+ employees. The company is currently Late Stage.